AC Immune SA - SHS (ACIU)

Historical Holders from Q3 2016 to Q3 2025

Symbol
ACIU on Nasdaq
Type / Class
Equity / SHS
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
24,623,944
Holdings value
$71,148,777
% of all portfolios
0%
Number of holders
40
Number of buys
17
Number of sells
-18
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AC Immune SA - SHS (ACIU)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 24,623,944 $71,148,777 +$686,928 $2.89 40
2025 Q2 24,501,946 $49,722,343 -$2,756,929 $2.03 41
2025 Q1 25,917,900 $48,452,492 -$3,728,120 $1.87 40
2024 Q4 27,368,510 $73,887,369 -$2,737,097 $2.7 44
2024 Q3 28,199,176 $106,590,963 -$1,853,215 $3.78 43
2024 Q2 28,573,335 $114,006,597 -$1,282,268 $3.99 44
2024 Q1 28,964,304 $85,733,267 -$2,967,065 $2.96 36
2023 Q4 29,638,667 $148,194,005 +$66,297,088 $5 32
2023 Q3 15,981,631 $45,548,797 -$162,676 $2.85 28
2023 Q2 16,033,728 $47,380,324 +$6,283,557 $2.96 31
2023 Q1 14,097,734 $32,988,033 -$1,216,472 $2.34 32
2022 Q4 14,762,259 $30,113,226 +$1,536,954 $2.04 36
2022 Q3 14,018,294 $44,297,207 +$516,565 $3.16 30
2022 Q2 13,801,401 $49,820,603 -$1,927,020 $3.61 32
2022 Q1 14,291,722 $57,166,356 -$3,455,706 $4 34
2021 Q4 15,047,623 $74,486,031 -$21,761,430 $4.95 43
2021 Q3 17,659,276 $118,497,474 -$4,034,573 $6.71 62
2021 Q2 18,193,441 $144,277,000 +$813,624 $7.93 56
2021 Q1 18,204,501 $138,526,610 -$11,134,919 $7.61 50
2020 Q4 19,803,074 $102,381,000 -$3,698,549 $5.17 45
2020 Q3 20,709,959 $101,062,895 +$1,419,309 $4.88 49
2020 Q2 20,384,455 $137,182,286 +$1,373,732 $6.73 40
2020 Q1 20,169,972 $139,370,146 +$7,129,511 $6.91 48
2019 Q4 19,092,604 $162,661,000 +$3,264,173 $8.52 48
2019 Q3 18,791,229 $93,011,000 +$3,303,962 $4.95 36
2019 Q2 18,070,499 $100,291,000 +$1,557,491 $5.55 39
2019 Q1 17,932,668 $90,557,000 -$29,291,694 $5.05 39
2018 Q4 20,248,444 $191,350,000 +$11,483,446 $9.45 38
2018 Q3 19,139,638 $153,117,000 +$63,511,328 $8 32
2018 Q2 10,991,993 $102,314,000 -$2,765,543 $9.31 15
2018 Q1 11,284,927 $116,687,000 +$935,616 $10.34 18
2017 Q4 11,172,927 $143,012,000 +$18,288,250 $12.8 21
2017 Q3 9,744,158 $109,858,000 -$3,309,337 $11.24 15
2017 Q2 10,277,545 $90,441,000 -$2,444,655 $8.8 17
2017 Q1 10,506,484 $108,837,000 +$18,140,263 $10.36 19
2016 Q4 8,747,097 $112,668,000 +$3,754,400 $12.98 19
2016 Q3 8,240,474 $135,720,000 +$135,720,000 $16.47 32